Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 17002
Country/Region: Dominican Republic
Year: 2016
Main Partner: John Snow, Inc
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: USAID
Total Funding: $2,261,471 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $119,459
Strategic Information (HVSI) $150,000
Health Systems Strengthening (OHSS) $250,000
Testing: HIV Testing and Counseling (HVCT) $311,715
Sexual Prevention: Other Sexual Prevention (HVOP) $347,502
Treatment: Adult Treatment (HTXS) $1,082,795
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: 20-24 Female 2017 15
GEND_GBV Age/Sex: 25-49 Female 2017 16
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 31
GEND_GBV Number of people receiving post-GBV care 2017 31
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 11,708
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 22,174
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 33,882
HTS_TST Service Delivery Point (Community): Other 2017 11,598
HTS_TST Service Delivery Point (Facility): Other PITC 2017 22,283
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 33,882
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 33,882
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 620
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,146
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 631
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 12,256
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 12,887
KP_PREV Total estimated number of key population in the catchment area 2017 78,736
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 34,681
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 44,055
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 602
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 602
TB_SCREENDX Screen Result: Screened Positive for TB 2017 669
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,350
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 3,352
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 6,702
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,722
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,725
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 7,447
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 7,447
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 7,447
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,450
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,450
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,900
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,900
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,957
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 4,766
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,268
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,271
TX_PVLS Numerator: Indication: Routine 2017 4,766
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 2,978
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 2,979
TX_PVLS_den Denominator: Indication: Routine 2017 5,957
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,930
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,935
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 3,865
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,547
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,272
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,275
Cross Cutting Budget Categories and Known Amounts Total: $1,800,000
Key Populations: MSM and TG $800,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $800,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Gender: Gender Based Violence (GBV) $200,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation